A profitable, cheaply-priced small-cap consumer lender: P/E ~6.9x, P/B ~0.91x, 3.5% dividend yield. Q1 2026 was strong (EPS +69% YoY, record revenue, operating-efficiency ratio at an all-time best). Base-case fair value β $39 vs ~$34.90 (+12%): real but contained upside. The central issue is credit-cycle risk β the portfolio is subprime/non-prime, delinquency signals are mixed, and management guided Q2 down sequentially. Book value provides a partial floor; the bear tail is heavy if unemployment rises. Cheap but not risk-free: a tactical value opportunity, not a defensive holding.
Methodology: probability-weighted fair value = 0.20Γ$48 + 0.50Γ$39 + 0.30Γ$27 β $37, slightly below the $39 base case β the bear tail weighs. The book-based anchor (BVPS ~$38.30 Γ ~1.05x = $40.22) is cross-checked against the earnings anchor (FY2026E EPS ~$5.50 Γ 7.75x peer = $42.6); both converge in the $40β43 area, then reduced by the credit-risk and illiquidity discounts. The key sensitivity is the net charge-off rate: every point above the ~10.5% expected level erodes ~$4β5/sh. of fair value. β οΈ Not investment advice.
| Component | Assumption | USD/share |
|---|---|---|
| Tangible book value / share | ~$38.30 est. at 3/31/26 (from $36.43 at Q2'25 + retained earnings, net of dividends and buybacks); negligible goodwill | +38.30 |
| Re-rating to ~1.05x book | Normalized ROE ~14% > cost of equity ~13% β equity merits a slight premium to book (+5%) | +1.92 |
| Above-book earnings power | FY2026E EPS ~$5.50 Γ 7.75x peer P/E = ~$42.6; partial credit for earnings above book value | +3.30 |
| Credit-cycle risk discount | Subprime/non-prime base, delinquency ticking up, Q2 guided lower, portfolio yields compressing | β3.00 |
| Micro-float illiquidity discount | ~9.2M shares outstanding, thin volume, price highly sensitive to single rating revisions | β1.50 |
| Base case fair value | 38.30 + 1.92 + 3.30 β 3.00 β 1.50 (arithmetic sum) | β $39.00 |
Short interest is very low and falling: the market is not expressing a structural bearish thesis on RM. Caution, if any, is macro (the consumer-credit cycle). Funding: RM accesses the ABS market regularly β in November 2025 it closed a $253M securitization (RMIT 2025-2) at a 4.83% weighted-average coupon β alongside revolving bank lines. Insider activity: director Roel C. Campos bought 953 shares at $32.07 through a dividend-reinvestment plan; no material insider selling (>$500K) in the last 12 months. No active class action or SEC investigation; the two-year CFPB supervisory period closed in January 2026 with no adverse findings.
| Item | FY2023 | FY2024 | FY2025 | FY2026E | Guidance 2026 |
|---|---|---|---|---|---|
| Revenue ($M) | ~565 | ~595 | ~645 | ~700 | Receivables growth β₯10% |
| Net finance receivables ($B) | ~1.74 | ~1.86 | 2.10 | ~2.30 | Ending balance β₯+10% |
| Net credit loss rate % | ~10.6% | ~11.7% | ~11.3% | ~10.5% | Improving |
| Net income ($M) | ~30 | ~24 | 44.4 | ~54 | Net income +20β25% |
| Diluted EPS ($) | ~3.10 | ~2.45 | ~4.50 | ~5.50 | n/d (no EPS guidance) |
| Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
| Revenue ($M) | 153.0 | 157.0 | 165.5 | 170.0 | 167.3 |
| Net credit loss rate % | 10.6 | 11.0 | 11.9 | 11.9 | 10.2 |
| Net income ($M) | 7.0 | 10.7 | 13.8 | 12.9 | 11.4 |
| Net finance receivables ($B) | 1.89 | 1.95 | 2.00 | 2.10 | 2.10 |
Business model β Regional Management
Large loans ~$1.75B (~83% of receivables) π’ growth engine Larger personal installment loans β the core of the portfolio and of growth. Mix shifting toward slightly higher-quality borrowers to contain the cost of risk. Small loans ~$0.30B (~14% of receivables) π‘ stable Smaller-ticket installment loans, higher yield but also higher losses. Serve as a customer-acquisition channel and cross-sell into large loans. Retail loans & insurance ~$0.05B + insurance income π΄ marginal / runoff Point-of-sale dealer financing (in gradual runoff) and optional insurance products. Modest receivables contribution, but insurance income is high-margin.
Legal, regulatory and risk analysis
SWOT analysis
- +Profitable and growing: Q1 EPS +69% YoY, record revenue.
- +Discounted valuation: P/E ~6.9x, P/B ~0.91x, 3.5% dividend.
- +Operating efficiency at an all-time best (12.2%) β scalable model.
- +Established, repeated access to the ABS market for funding.
- +Portfolio growing +11% YoY with an entrenched branch network.
- βSubprime/non-prime customer base, structurally fragile.
- βROE ~12β14%, below larger-scale peers (OMF, ENVA).
- βMicro-float ~9.2M shares: liquidity and volatility penalize.
- β2026 EPS estimates being revised down; Q2 guided lower.
- βA drop in rates would cut funding costs and widen the spread.
- βRe-rating possible if the cost of risk stays under control.
- βBelow-book buybacks are accretive to value per share.
- βMix shift toward higher-quality borrowers.
- !Recession / rising unemployment β spike in net charge-offs.
- !Tightening of credit markets β more expensive funding.
- !Regulatory tightening on rates and ancillary products.
- !Competition from online lenders and larger-scale peers.
Summary by assessment area
- Subprime base: first to deteriorate in a recession.
- Net credit loss 10.2% in Q1, but Q2 guided to lower earnings.
- Allowance of 10.4% adequate for the current scenario.
- Q1 EPS +69% YoY, record revenue, efficiency at an all-time low.
- FY2026 net income guided +20β25%, ROE toward ~14%.
- 3.5% dividend + below-book buybacks.
- Base FV ~$39 vs ~$34.90 β upside +12%.
- P/E ~6.9x, P/B ~0.91x: discount vs peers.
- Heavy bear tail: probability-weighted FV ~$37.
Sources: Regional Management Corp. 8-K / press releases (Q1 2026 results 2026-04-29; FY2025/Q4 results 2026-02-04), Form 10-Q Q1 2026, DEF 14A 2026, company investor relations; market data from Yahoo Finance, CNBC, Investing.com, StockAnalysis, Ticker Report; analyst commentary from Zacks, Simply Wall St, The Motley Fool, Citizens Investment Research. Market data (2026-05-22 β latest available close May 20, 2026, cross-checked on β₯2 recent sources): RM ~$34.90, market cap ~$321M, 52W range $26.06β$46.00, ~9.2M shares outstanding. Short interest ~2.7% (243,900 shares as of 5/15/26). P/E TTM ~6.9x; book value per share ~$38.30 estimated at 3/31/26 (from $36.43 at Q2'25); net finance receivables $2.10B; allowance 10.4%; Q1 2026 net credit loss rate 10.2%. This document is for informational purposes only and does not constitute financial or investment advice.